Collagen Metabolites in Osteosarcoma Patients
Author Information
Author(s): T Wiklund, C Blomqvist, L Risteli, J Risteli, E Karaharju, I Elomaal
Primary Institution: University of Helsinki
Hypothesis
The study investigates the relationship between collagen metabolites and outcomes in osteosarcoma patients.
Conclusion
The study found that collagen metabolites did not predict outcomes in osteosarcoma patients, and their levels changed inconsistently with disease progression.
Supporting Evidence
- Collagen metabolites were measured in 39 osteosarcoma patients.
- Elevated concentrations of type I and III collagen metabolites were frequent in untreated osteogenic sarcoma.
- None of the collagen metabolites were prognostic factors for survival at baseline.
Takeaway
Doctors looked at special proteins in the blood of young people with bone cancer to see if they could tell how sick they were, but they found that these proteins didn't really help.
Methodology
The study measured three collagen metabolites in serum samples from osteosarcoma patients before and after treatment.
Limitations
The study's findings may not apply to older patients as the majority were young.
Participant Demographics
The mean age of patients was 22 years, with a range from 15 to 55 years, and included both men and women.
Statistical Information
P-Value
0.02
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website